Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Amortizatization of Intangibles: 2020-2025

Historic Amortizatization of Intangibles for Avidity Biosciences (RNA) over the last 5 years, with Sep 2025 value amounting to $2.4 million.

  • Avidity Biosciences' Amortizatization of Intangibles fell 64.87% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 million, marking a year-over-year increase of 3.91%. This contributed to the annual value of $21.4 million for FY2024, which is 90.23% up from last year.
  • As of Q3 2025, Avidity Biosciences' Amortizatization of Intangibles stood at $2.4 million, which was down 30.79% from $3.5 million recorded in Q2 2025.
  • In the past 5 years, Avidity Biosciences' Amortizatization of Intangibles registered a high of $7.2 million during Q4 2024, and its lowest value of -$40,000 during Q1 2021.
  • Its 3-year average for Amortizatization of Intangibles is $4.0 million, with a median of $3.2 million in 2023.
  • Per our database at Business Quant, Avidity Biosciences' Amortizatization of Intangibles skyrocketed by 8,788.89% in 2021 and then tumbled by 64.87% in 2025.
  • Avidity Biosciences' Amortizatization of Intangibles (Quarterly) stood at $782,000 in 2021, then dropped by 12.92% to $681,000 in 2022, then surged by 375.33% to $3.2 million in 2023, then spiked by 121.38% to $7.2 million in 2024, then plummeted by 64.87% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $3.5 million for Q2 2025, and $5.2 million during Q1 2025.